Brain Tumor Drugs Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Brain Tumor Drugs Market
1.1. Definition and Scope
1.1.1. Definition of Brain Tumor Drugs
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Brain Tumor Drugs Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Brain Tumor Drugs Market By Therapy Type
1.2.3. Brain Tumor Drugs Market By Indication
1.2.4. Brain Tumor Drugs Market By Distribution Channel
1.2.5. Brain Tumor Drugs Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Brain Tumor Drugs Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Brain Tumor Drugs Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2022
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Brain Tumor Drugs Market By Therapy Type
4.1. Introduction
4.2. Brain Tumor Drugs Revenue By Therapy Type
4.2.1. Brain Tumor Drugs Revenue (USD Billion) and Forecast, By Therapy Type, 2020-2032
4.2.2. Targeted Therapy
4.2.2.1. Targeted Therapy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.3. Chemotherapy
4.2.3.1. Chemotherapy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.4. Immunotherapy
4.2.4.1. Immunotherapy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.5. Others
4.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 5. Brain Tumor Drugs Market By Indication
5.1. Introduction
5.2. Brain Tumor Drugs Revenue By Indication
5.2.1. Brain Tumor Drugs Revenue (USD Billion) and Forecast, By Indication, 2020-2032
5.2.2. Pituitary Tumors
5.2.2.1. Pituitary Tumors Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Meningioma
5.2.3.1. Meningioma Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Glioblastoma
5.2.4.1. Glioblastoma Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Others
5.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Brain Tumor Drugs Market By Distribution Channel
6.1. Introduction
6.2. Brain Tumor Drugs Revenue By Distribution Channel
6.2.1. Brain Tumor Drugs Revenue (USD Billion) and Forecast, By Distribution Channel, 2020-2032
6.2.2. Hospital Pharmacy
6.2.2.1. Hospital Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Retail Pharmacy
6.2.3.1. Retail Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Others
6.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Brain Tumor Drugs Market By Country
7.1. North America Brain Tumor Drugs Market Overview
7.2. U.S.
7.2.1. U.S. Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
7.2.2. U.S. Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
7.2.3. U.S. Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
7.3. Canada
7.3.1. Canada Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
7.3.2. Canada Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
7.3.3. Canada Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Brain Tumor Drugs Market By Country
8.1. Europe Brain Tumor Drugs Market Overview
8.2. U.K.
8.2.1. U.K. Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
8.2.2. U.K. Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
8.2.3. U.K. Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.3. Germany
8.3.1. Germany Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
8.3.2. Germany Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
8.3.3. Germany Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.4. France
8.4.1. France Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
8.4.2. France Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
8.4.3. France Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.5. Spain
8.5.1. Spain Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
8.5.2. Spain Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
8.5.3. Spain Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
8.6.2. Rest of Europe Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
8.6.3. Rest of Europe Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Brain Tumor Drugs Market By Country
9.1. Asia Pacific Brain Tumor Drugs Market Overview
9.2. China
9.2.1. China Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
9.2.2. China Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.2.3. China Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.3. Japan
9.3.1. Japan Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
9.3.2. Japan Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.3.3. Japan Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.4. India
9.4.1. India Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
9.4.2. India Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.4.3. India Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.5. Australia
9.5.1. Australia Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
9.5.2. Australia Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.5.3. Australia Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.6. South Korea
9.6.1. South Korea Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
9.6.2. South Korea Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.6.3. South Korea Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
9.7.2. Rest of Asia-Pacific Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.7.3. Rest of Asia-Pacific Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Brain Tumor Drugs Market By Country
10.1. Latin America Brain Tumor Drugs Market Overview
10.2. Brazil
10.2.1. Brazil Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
10.2.2. Brazil Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.2.3. Brazil Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.3. Mexico
10.3.1. Mexico Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
10.3.2. Mexico Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.3.3. Mexico Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
10.4.2. Rest of Latin America Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.4.3. Rest of Latin America Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Brain Tumor Drugs Market By Country
11.1. Middle East & Africa Brain Tumor Drugs Market Overview
11.2. GCC
11.2.1. GCC Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
11.2.2. GCC Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.2.3. GCC Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.3. South Africa
11.3.1. South Africa Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
11.3.2. South Africa Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.3.3. South Africa Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Brain Tumor Drugs Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
11.4.2. Rest of Middle East & Africa Brain Tumor Drugs Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.4.3. Rest of Middle East & Africa Brain Tumor Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Brain Tumor Drugs Market
12.1. Brain Tumor Drugs Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Brain Tumor Drugs Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. AbbVie Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2022
13.1.3.2. AbbVie Inc. 2022 Brain Tumor Drugs Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Amgen Inc.
13.3. AstraZeneca
13.4. Bayer AG
13.5. Bristol-Myers Squibb
13.6. Eisai Co., Ltd.
13.7. Eli Lilly and Company
13.8. F. Hoffmann-La Roche Ltd
13.9. Ipsen Biopharmaceuticals, Inc.
13.10. Johnson & Johnson
13.11. Merck & Co, Inc.
13.12. Novartis AG
13.13. Pfizer Inc.
13.14. Sanofi SA
Frequently Asked Questions
What was the market size of the global brain tumor drugs in 2022?
The market size of brain tumor drugs was USD 2.8 billion in 2022.
What is the CAGR of the global brain tumor drugs market from 2023 to 2032?
The CAGR of brain tumor drugs is 8.8% during the analysis period of 2023 to 2032.
Which are the key players in the brain tumor drugs market?
The key players operating in the global market are including AbbVie Inc., Amgen Inc., AstraZeneca, Bayer AG, Bristol-Myers Squibb, Eisai Co., Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Ipsen Biopharmaceuticals, Inc., Johnson & Johnson, Merck & Co, Inc., Novartis AG, Pfizer Inc, and Sanofi SA.
Which region dominated the global brain tumor drugs market share?
North America held the dominating position in brain tumor drugs industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of brain tumor drugs during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global brain tumor drugs industry?
The current trends and dynamics in the brain tumor drugs industry include increasing prevalence of brain tumors, technological advancements in brain tumor diagnosis, and growing demand for personalized medicines.
Which therapy type held the maximum share in 2022?
The chemotherapy therapy type held the maximum share of the brain tumor drugs industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
